HRMY - Harmony Biosciences Holdings Inc


28.79
0.050   0.174%

Share volume: 544,083
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.16%

PREVIOUS CLOSE
CHG
CHG%

$28.74
0.05
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 04-30-2024 08-06-2024 10-29-2024 02-25-2025 05-06-2025 11-04-2025 02-24-2026
Total revenue 154.615 M 172.814 M 186.038 M 201.267 M 184.733 M 239.455 M 243.776 M
Cost of revenue 27.484 M 32.144 M 42.778 M 54.409 M 31.994 M 59.650 M 68.545 M
Gross profit 127.131 M 140.670 M 143.260 M 146.858 M 152.739 M 179.805 M 175.231 M
    10.65% 1.84% 2.51% 4.00% 17.72% -2.54%  
Operating expenses 47.865 M 90.807 M 53.974 M 63.531 M 65.783 M 84.769 M 107.495 M
Selling general and admin 25.676 M 27.224 M 28.587 M 28.865 M 31.243 M 29.807 M 57.562 M
Research and development 22.189 M 63.583 M 25.387 M 34.666 M 34.540 M 54.962 M 49.933 M
Total expenses 75.098 M 119.314 M 81.550 M 91.131 M 96.494 M 114.318 M 136.674 M
    58.88% -31.65% 11.75% 5.88% 18.47% 19.56%  
Operating income 52.033 M 21.356 M 61.710 M 55.727 M 56.245 M 65.487 M 38.557 M
Ebit 51.892 M 21.393 M 61.586 M 55.887 M 55.969 M 65.381 M 38.452 M
Pretax income 51.785 M 21.694 M 62.170 M 56.155 M 57.177 M 67.490 M 40.760 M
    -58.11% 186.58% -9.68% 1.82% 18.04% -39.61%  
Income tax 13.451 M 10.103 M 16.077 M 6.680 M 11.617 M 16.625 M 18.274 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income 38.334 M 11.591 M 46.093 M 49.475 M 45.560 M 50.865 M 22.486 M
    -69.76% 297.66% 7.34% -7.91% 11.64% -55.79%